Could de-stressing the brain be the solution for long-term weight loss?

Area of Science:

• Neuroscience
• Metabolic disease research
• Endocrinology

Background:

• Obesity is linked to hypothalamic stress and inflammation affecting neurons and glial cells.
• Leptin, a key hormone for appetite control, becomes ineffective (leptin resistance) in obesity.
• Endoplasmic reticulum (ER) stress in hypothalamic cells contributes to obesity-related dysfunction.

Purpose of the Study:

• To investigate the effects of pharmacological agents and bariatric surgery on hypothalamic stress and inflammation.
• To explore the potential of restoring hypothalamic function for weight management.

Main Methods:

• Utilized rodent models to study the impact of celastrol and withaferin-A on hypothalamic ER stress.
• Examined the effects of vertical sleeve gastrectomy (VSG) on hypothalamic inflammation, gliosis, and neuronal function in obese models.

Main Results:

• Celastrol and withaferin-A relieved hypothalamic ER stress, reversed leptin resistance, and induced significant weight loss.
• VSG demonstrated similar effects to pharmacological treatments, reducing hypothalamic inflammation and gliosis.
• Both approaches restored healthy hypothalamic neuronal and glial cell function.

Conclusions:

• Targeting hypothalamic neuronal and glial cell stress and inflammation is a viable strategy for combating obesity.
• Pharmacological interventions and bariatric surgery (VSG) can restore hypothalamic function and promote negative energy balance.
• Re-establishing adipose tissue-brain communication via hypothalamic health is crucial for weight management.